Position in QGEN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,902,792
-$10,458,231 QoQ
Shares Held
176,542
-59.3% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#86
of 336 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Derivatives in QGEN
reported options exposure · as of Mar 31, 2025CallValue
$6,022,500
CallShares
150,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $727,870,777 across 19 Diagnostics & Research names. QGEN ranks #9 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
449,628 | $225,425,494 | |
| 2 | DHR |
Danaher Corp /De/
|
759,207 | $144,613,749 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
700,425 | $135,336,117 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
54,686 | $69,861,911 | |
| 5 | DGX |
Quest Diagnostics Inc
|
275,371 | $58,364,883 | |
| 6 | WAT |
Waters Corp /De/
|
138,443 | $51,921,662 | |
| 7 | GH |
Guardant Health, Inc.
|
124,368 | $18,658,930 | |
| 8 | RVTY |
Revvity, Inc.
|
63,056 | $7,015,610 |
All Filings in QGEN
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,902,792 | 176,542 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $17,361,023 | 433,592 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,642,086 | 436,782 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $38,173,966 | 854,386 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $15,674,336 | 326,141 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,760,721 | 392,546 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $6,022,500 | 150,000 | Call | Sole | 2025-05-15 | |
| 2024-12-31 | $3,176,503 | 71,334 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,132,865 | 200,414 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,187,697 | 272,273 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,560,990 | 82,833 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $16,229,015 | 362,098 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,150,161 | 195,000 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $44,610,473 | 1,067,346 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $70,368,864 | 1,484,594 | Shares | Sole | 2023-05-15 | |
| 2023-03-31 | $3,080,961 | 65,000 | Call | Sole | 2023-05-15 | |
| 2022-12-31 | $69,776,789 | 1,355,800 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,307,117 | 195,000 | Call | Sole | 2022-11-15 | |
| 2022-09-30 | $45,036,416 | 1,057,178 | Shares | Other | 2022-11-15 | |
| 2022-06-30 | $68,671,017 | 1,409,793 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,079,464 | 140,000 | Call | Sole | 2022-05-16 | |
| 2022-03-31 | $51,925,592 | 1,026,855 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $29,052,393 | 506,509 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $91,500,849 | 1,715,642 | Shares | Sole | 2021-12-01 | |
| 2021-09-30 | $37,663,976 | 706,200 | Call | Sole | 2021-12-01 | |
| 2021-06-30 | $30,677,936 | 614,446 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $19,494,047 | 387,959 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $6,741,487 | 125,000 | Call | Sole | 2020-11-16 | |
| 2020-09-30 | $21,371,971 | 396,277 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $84,754,984 | 1,918,419 | Shares | Sole | 2020-08-14 | |
| 2020-06-30 | $5,018,802 | 113,600 | Call | Sole | 2020-08-14 | |
| 2020-03-31 | $58,615,360 | 1,365,342 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||